These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18644416)

  • 1. Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology.
    Letellier C; Boxus M; Rosar L; Toussaint JF; Walravens K; Roels S; Meyer G; Letesson JJ; Kerkhofs P
    Vaccine; 2008 Sep; 26(37):4840-8. PubMed ID: 18644416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.
    Boxus M; Tignon M; Roels S; Toussaint JF; Walravens K; Benoit MA; Coppe P; Letesson JJ; Letellier C; Kerkhofs P
    J Virol; 2007 Jul; 81(13):6879-89. PubMed ID: 17459933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
    Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccination against respiratory syncytial virus in young calves.
    Taylor G; Bruce C; Barbet AF; Wyld SG; Thomas LH
    Vaccine; 2005 Jan; 23(10):1242-50. PubMed ID: 15652666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on cytokine messenger RNA expression following viral challenge in calves.
    Miao C; Woolums AR; Zarlenga DS; Brown CC; Brown JC; Williams SM; Scott MA
    Am J Vet Res; 2004 Jun; 65(6):725-33. PubMed ID: 15198210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.
    Riffault S; Meyer G; Deplanche M; Dubuquoy C; Durand G; Soulestin M; Castagné N; Bernard J; Bernardet P; Dubosclard V; Bernex F; Petit-Camurdan A; Deville S; Schwartz-Cornil I; Eléouët JF
    Vaccine; 2010 May; 28(21):3722-34. PubMed ID: 20307593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an inactivated respiratory syncytial virus vaccine in calves.
    Ellis J; West K; Konoby C; Leard T; Gallo G; Conlon J; Fitzgerald N
    J Am Vet Med Assoc; 2001 Jun; 218(12):1973-80. PubMed ID: 11417745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
    Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
    PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
    Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
    Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves.
    Hägglund S; Hu K; Vargmar K; Poré L; Olofson AS; Blodörn K; Anderson J; Ahooghalandari P; Pringle J; Taylor G; Valarcher JF
    Vaccine; 2011 Nov; 29(47):8719-30. PubMed ID: 21864616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection.
    Antonis AF; Claassen EA; Hensen EJ; de Groot RJ; de Groot-Mijnes JD; Schrijver RS; van der Most RG
    Vaccine; 2006 Mar; 24(10):1551-61. PubMed ID: 16310293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.
    Ellis JA; West KH; Waldner C; Rhodes C
    Can Vet J; 2005 Feb; 46(2):155-62. PubMed ID: 15825518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves.
    Woolums AR; Brown CC; Brown JC; Cole DJ; Scott MA; Williams SM; Miao C
    Am J Vet Res; 2004 Mar; 65(3):363-72. PubMed ID: 15027687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV.
    Woolums AR; Singer RS; Boyle GA; Gershwin LJ
    Vaccine; 1999 Mar; 17(11-12):1293-7. PubMed ID: 10195762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge.
    Woolums AR; Gunther RA; McArthur-Vaughan K; Anderson ML; Omlor A; Boyle GA; Friebertshauser KE; McInturff PS; Gershwin LJ
    Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):57-74. PubMed ID: 14656542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves.
    West K; Petrie L; Konoby C; Haines DM; Cortese V; Ellis JA
    Vaccine; 1999 Dec; 18(9-10):907-19. PubMed ID: 10580205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
    Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves.
    Kalina WV; Woolums AR; Gershwin LJ
    Vaccine; 2005 Aug; 23(37):4625-30. PubMed ID: 15967545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.